Characterization of the impairment of the uptake of apoptotic polymorphonuclear cells by monocyte subpopulations in systemic lupus erythematosus

Lupus

Volumn 23, Issue 13, 2014, Pages 1358-1369

  Mikolajczyk T P ^a   Skiba, D ^a   Batko, B ^a   Krezelok, M ^a   Wilk, G ^a   Osmenda, G ^a   Pryjma, J R ^b   Guzik, T J ^a,c  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

monocyte; neutrophil; phagocytosis; Systemic lupus erythematosus

Indexed keywords

AZATHIOPRINE; CD14 ANTIGEN; CD16 ANTIGEN; CHLOROQUINE; COMPLEMENT COMPONENT C3B RECEPTOR; CYCLOPHOSPHAMIDE; CYTOKINE; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 10; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; FC RECEPTOR; HAVCR2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CHRONIC INFLAMMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE SYSTEM; MACROPHAGE; MALE; MONOCYTE; PHAGOCYTOSIS; PHASE 1 CLINICAL TRIAL; POLYMORPHONUCLEAR CELL; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; BIOSYNTHESIS; CASE CONTROL STUDY; CHEMISTRY; DRUG EFFECTS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; MONONUCLEAR CELL; NEUTROPHIL; PHYSIOLOGY; YOUNG ADULT;

ADULT; ANTIGENS, CD; ANTIGENS, CD14; APOPTOSIS; CASE-CONTROL STUDIES; FEMALE; HUMANS; INTERLEUKIN-10; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MONOCYTES; NEUTROPHILS; PHAGOCYTOSIS; RECEPTORS, COMPLEMENT 3B; RECEPTORS, IGG; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84909641212     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203314541316     Document Type: Article

References (43)

1. Voll RE, Herrmann M, Roth EA, Stach C, Kalden JR, Girkontaite I. Immunosuppressive effects of apoptotic cells. Nature. 1997 ; 390: 350-351
2. Fadok VA, Bratton DL, Konowal A, Freed PW, Westcott JY, Henson PM. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998 ; 101: 890-898
3. Chung EY, Kim SJ, Ma XJ. Regulation of cytokine production during phagocytosis of apoptotic cells. Cell Res. 2006 ; 16: 154-161
4. Botto M, Dell'Agnola C, Bygrave AE, et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet. 1998 ; 19: 56-59
5. Paul E, Pozdnyakova OO, Mitchell E, Carroll MC. Anti-DNA autoreactivity in C4-deficient mice. Eur J Immunol. 2002 ; 32: 2672-2679
6. Hanayama R, Tanaka M, Miyasaka K, et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science. 2004 ; 304: 1147-1150
7. Szalai AJ, Weaver CT, McCrory MA, et al. Delayed lupus onset in (NZB×NZW)F1 mice expressing a human C-reactive protein transgene. Arthritis Rheum. 2003 ; 48: 1602-1611
8. Herrmann M, Voll RE, Zoller OM, Hagenhofer M, Ponner BB, Kalden JR. Impaired phagocytosis of apoptotic cell material by monocyte-derived macrophages from patients with systemic lupus erythematosus. Arthritis Rheum. 1998 ; 41: 1241-1250
9. Ren Y, Tang J, Mok MY, Chan AW, Wu A, Lau CS. Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus. Arthritis Rheum. 2003 ; 48: 2888-2897
10. Fossati-Jimack L, Ling GS, Cortini A, et al. Phagocytosis is the main CR3-mediated function affected by the lupus-associated variant of CD11b in human myeloid cells. PloS One. 2013 ; 8: e57082 - e57082
11. Shlomchik MJ, Craft JE, Mamula MJ. From T to B and back again: Positive feedback in systemic autoimmune disease. Nat Rev Immunol. 2001 ; 1: 147-153
12. Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest. 1992 ; 90: 1513-1522
13. Ren Y, Silverstein RL, Allen J, Savill J. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis. J Exp Med. 1995 ; 181: 1857-1862
14. Mevorach D, Mascarenhas JO, Gershov D, Elkon KB. Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med. 1998 ; 188: 2313-2320
15. Mikolajczyk TP, Skrzeczynska-Moncznik JE, Zarebski MA, et al. Interaction of human peripheral blood monocytes with apoptotic polymorphonuclear cells. Immunology. 2009 ; 128: 103-113
16. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982 ; 25: 1271-1277
17. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992 ; 35: 630-640
18. Horan PK, Slezak SE. Stable cell membrane labelling. Nature. 1989 ; 340: 167-168
19. Nakayama M, Akiba H, Takeda K, et al. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood. 2009 ; 113: 3821-3830
20. Korb LC, Ahearn JM. C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: Complement deficiency and systemic lupus erythematosus revisited. J Immunol. 1997 ; 158: 4525-4528
21. Gardai SJ, Xiao YQ, Dickinson M, et al. By binding SIRPalpha or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell. 2003 ; 115: 13-23
22. Basu S, Binder RJ, Ramalingam T, Srivastava PK. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity. 2001 ; 14: 303-313
23. Brown S, Heinisch I, Ross E, Shaw K, Buckley CD, Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 2002 ; 418: 200-203
24. Courtney PA, Crockard AD, Williamson K, Irvine AE, Kennedy RJ, Bell AL. Increased apoptotic peripheral blood neutrophils in systemic lupus erythematosus: Relations with disease activity, antibodies to double stranded DNA, and neutropenia. Ann Rheum Dis. 1999 ; 58: 309-314
25. Yassin LM, Rojas M, Ramírez LA, García LF, Vásquez G. Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients. Cell Immunol. 2010 ; 266: 52-60
26. Bijl M, Reefman E, Horst G, Limburg PC, Kallenberg CG. Reduced uptake of apoptotic cells by macrophages in systemic lupus erythematosus: Correlates with decreased serum levels of complement. Ann Rheum Dis. 2006 ; 65: 57-63
27. Donnelly S, Roake W, Brown S, et al. Impaired recognition of apoptotic neutrophils by the C1q/calreticulin and CD91 pathway in systemic lupus erythematosus. Arthritis Rheum. 2006 ; 54: 1543-1556
28. Fadok VA, Voelker DR, Campbell PA, Cohen JJ, Bratton DL, Henson PM. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J Immunol. 1992 ; 148: 2207-2216
29. Greenberg ME, Sun M, Zhang R, Febbraio M, Silverstein R, Hazen SL. Oxidized phosphatidylserine-CD36 interactions play an essential role in macrophage-dependent phagocytosis of apoptotic cells. J Exp Med. 2006 ; 203: 2613-2625
30. Cairns AP, Crockard AD, Bell AL. Complement receptor expression of relevance to apoptotic cell clearance in SLE. Rheumatology (Oxford). 2003 ; 42: 487-488
31. Du WT, Zhao HF, Xu JH, et al. The role of T-cell immunoglobulin- and mucin-domain-containing molecule-3 polymorphisms in idiopathic thrombocytopenic purpura. Hum Immunol. 2009 ; 70: 398-402
32. Chae SC, Park YR, Shim SC, Yoon KS, Chung HT. The polymorphisms of Th1 cell surface gene Tim-3 are associated in a Korean population with rheumatoid arthritis. Immunol Lett. 2004 ; 95: 91-95
33. Wang Y, Meng J, Wang X, et al. Expression of human TIM-1 and TIM-3 on lymphocytes from systemic lupus erythematosus patients. Scand J Immunol. 2008 ; 67: 63-70
34. Pan HF, Zhang N, Li WX, Tao JH, Ye DQ. TIM-3 as a new therapeutic target in systemic lupus erythematosus. Mol Biol Rep. 2010 ; 37: 395-398
35. Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus. Mol Immunol. 2004 ; 41: 449-456
36. Hepburn AL, Mason JC, Davies KA. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis. Rheumatology (Oxford). 2004 ; 43: 547-554
37. Bzowska M, Guzik K, Barczyk K, Ernst M, Flad HD, Pryjma J. Increased IL-10 production during spontaneous apoptosis of monocytes. Eur J Immunol. 2002 ; 32: 2011-2020
38. Byrne A, Reen DJ. Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils. J Immunol. 2002 ; 168: 1968-1977
39. Park YB, Lee SK, Kim DS, Lee J, Lee CH, Song CH. Elevated interleukin-10 levels correlated with disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 1998 ; 16: 283-288
40. Llorente L, Zou W, Levy Y, et al. Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus. J Exp Med. 1995 ; 181: 839-844
41. Llorente L, Garcia-Padilla C, Richaud-Patin Y, et al. Treatment of systemic lupus erythematosus with an anti-IL-10 monoclonal antibody: Clinical and biological aspects. Milan, Italy, 27-29 May 1999, the 2nd International IL-10 Workshop.
42. Sun Z, Zhang R, Wang H, et al. Serum IL-10 from systemic lupus erythematosus patients suppresses the differentiation and function of monocyte-derived dendritic cells. J Biomed Res. 2012 ; 26: 456-466
43. Fagiolo E, Terenzi CT. Enhanced IL-10 production in vitro by monocytes in autoimmune haemolytic anaemia. Immunol Invest. 1999 ; 28: 347-352